Nicotine-mediated effects in neuronal and mouse models of synucleinopathy

Alpha-synuclein seed amplification assays: Data sharing, standardization needed for clinical use

" Reverse engineering Lewy bodies: How far have we come and how far can we go?": Correction.

Context dependent reduction of tumor phenotype by connexin-43 overexpression in MDA-MB-231 cells involvement of B [Beta]-catenin signaling-by Mohamed-Bilal Mashary Fares

α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer

The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear …

Characterization of semisynthetic and naturally Nα-acetylated α-synuclein in vitro and in intact cells: implications for aggregation and cellular properties of α-synuclein

Reverse engineering Lewy bodies: how far have we come and how far can we go?

Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson’s disease

N-terminal Huntingtin (Htt) phosphorylation is a molecular switch regulating Htt aggregation, helical conformation, internalization, and nuclear targeting

Parkinson disease mutant E46K enhances α-synuclein phosphorylation in mammalian cell lines, in yeast, and in vivo

Context dependent reversion of tumor phenotype by connexin-43 expression in MDA-MB231 cells and MCF-7 cells: Role of β-catenin/connexin43 association

Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN Proteoforms

Anti‐Inflammatory and Cytostatic Activities of a Parthenolide‐Like Sesquiterpene Lactone from Cota palaestina subsp. syriaca